Last edition
News about "Alkermes"
Alkermes Enters Sleep Medicine Arena with USD 2.1 Billion Acquisition of Avadel
Alkermes plc has announced it will acquire Avadel Pharmaceuticals in a deal valued at up to USD 2.1 billion, marking the company’s strategic entry into the sleep medicine market.
Alkermes | 24/10/2025 | By Darshana
Alkermes appoints Joshua Reed as CFO
The newly-appointed CFO at Alkermes, Joshua Reed, brings over 30 years of financial leadership experience, with a strong focus in the biotechnology and pharmaceutical sectors. Most recently, he served as CFO of Omega Therapeutics.
Alkermes | 13/09/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy